Changing behavior in clinical practice in response to the ACOSOG Z0011 trial: A survey of the American Society of Breast Surgeons

Annals of Surgical Oncology

Volumn 19, Issue 10, 2012, Pages 3152-3158

  Gainer, Sarah M ^a   Hunt, Kelly K ^a   Beitsch, Peter ^b   Caudle, Abigail S ^a   Mittendorf, Elizabeth A ^a   Lucci, Anthony ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Dallas Surgical Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER SURGERY; CLINICAL PRACTICE; HUMAN; LYMPH NODE METASTASIS; MEDICAL SOCIETY; ONCOLOGY; PARTIAL MASTECTOMY; PRIVATE PRACTICE; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; SURGEON; UNITED STATES;

BREAST NEOPLASMS; DECISION MAKING; FEMALE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; QUESTIONNAIRES; SOCIETIES, MEDICAL;

EID: 84868213425     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2523-z     Document Type: Article

References (28)

1. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985; 312:674-81. (Pubitemid 15134703)
2. Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989;320:822-28. (Pubitemid 19094701)
3. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year followup of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227-32. (Pubitemid 35176241)
4. Van Bongen JA, Bartelink H, Fentiman I, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr. 1992;11:15-8.
5. Blichert-Toft M, Nielsen M, During M, et al. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82™ protocol. Acta Oncol. 2008;47:672-81. (Pubitemid 351878447)
6. Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995;332:907-11.
7. Sarrazin D, Le MG, Arriagada R, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol. 1989;14:177-84. (Pubitemid 19087084)
8. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-8.
9. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222:394-9.
10. Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymphnode dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomized phase III trial. Lancet Oncol. 2007;8:881-8. (Pubitemid 47488052)
11. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546-53. (Pubitemid 36951366)
12. Veronesi U, Viale G, Paganelli G, et al. Sentinel lymph node biopsy in breast cancer ten-year results of a randomized controlled study. Ann Surg. 2010;251:595-600.
13. Ashikaga T, Krag DN, Land SR, et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010;102:111-8.
14. Lucci A, Mackie McCall L, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group trial Z0011. J Clin Oncol. 2007;25:3657-63. (Pubitemid 47372604)
15. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569-75.
16. Lyman GH, Guiliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703-20. (Pubitemid 46291835)
17. National Comprehensive Cancer Network (NCCN) Clinical practice guidelines in oncology: breast, version 1.2012. www.nccn.org/professionals/physician-gls/ pdf/breast.pdf (2012). Accessed 20 Feb 2012.
18. The American Society of Breast Surgeons position statement on management of the axilla in patients with invasive breast cancer. http://www. breastsurgeons.org/statements/PDF-Statements/Axillary-Management.pdf (2011). Accessed 14 Nov 2011.
19. Caudle AS, Hunt KK, Kuerer HM, et al. Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial. Ann Surg Oncol. 2011;18: 2407-12.
20. Jeruss JS, Winchester DJ, and Sener SF, et al. Axillary recurrence after sentinel node biopsy. Ann Surg Oncol. 2005;12:34-40. (Pubitemid 40486639)
21. Hwang R, Gonzalez-A ngulo AM, Yi M, et al. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer. 2007;110:723-30. (Pubitemid 47257646)
22. Barkley C, Burstein H, Smith B, et al. Can axillary node dissection be omitted in a subset of patients with low local and regional failure rates? Breast J. 2012;18:23-7.
23. Galimberti V, Botteri E, Chifu C, et al. Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer? Breast Cancer Res Treat. 2012;131:819-25.
24. Yi M, Giordano SH, Meric-Bernstam F, et al. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol. 2010;17:343-51.
25. Bilimoria KY, Bentrem DJ, Hansen NM, et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol. 2009;27:2946-53.
26. Haffty BG, Hunt KK, Harris JR, and Buchholz TA. Positive sentinel nodes without axillary dissection: implications for the radiation oncologist. J Clin Oncol. 2011;29:4479-81.
27. Morrow M and Giuliano AE. To cut is to cure: can we really apply Z0011 in practice? Ann Surg Oncol. 2011;18:2413-15.
28. Galimberti V, Cole BF, Zurrida S, et al. Update of International Breast Cancer Study Group trial 23-01 to compare axillary dissection versus no axillary dissection in patients with clinically node negative breast cancer and micrometastases in the sentinel node. Cancer Res. 2011;71(suppl):102S.